Skip to main content
. Author manuscript; available in PMC: 2015 Sep 28.
Published in final edited form as: J Control Release. 2014 Jun 28;190:314–330. doi: 10.1016/j.jconrel.2014.06.028

Figure 2.

Figure 2

ELP unimers confer improved pharmacokinetics to therapeutic protein fusions. Anti-TNF antibody fused to an ELP unimer expressed in Nicotiana tabacum (NTTNF-VHHELP) exhibited increased serum half-life (t1/2) as compared to free anti-TNF antibody expressed in E. coli (EcTNF-VHH) following intravenous injection in mice. Adapted from [18]. Copyright 2011 John Wiley & Sons.